VETRANO, ERICA
 Distribuzione geografica
Continente #
EU - Europa 2.448
AS - Asia 954
NA - Nord America 642
SA - Sud America 150
AF - Africa 13
Totale 4.207
Nazione #
RU - Federazione Russa 2.003
US - Stati Uniti d'America 620
SG - Singapore 326
CN - Cina 237
IT - Italia 160
HK - Hong Kong 158
IE - Irlanda 130
BR - Brasile 120
KR - Corea 70
VN - Vietnam 60
DE - Germania 44
IN - India 42
GB - Regno Unito 30
FR - Francia 18
JP - Giappone 13
MX - Messico 13
FI - Finlandia 8
AR - Argentina 7
AT - Austria 7
SE - Svezia 7
CO - Colombia 6
EG - Egitto 6
ID - Indonesia 6
PK - Pakistan 6
PL - Polonia 6
TR - Turchia 6
CA - Canada 5
NL - Olanda 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
BD - Bangladesh 4
PE - Perù 4
CH - Svizzera 3
DK - Danimarca 3
EC - Ecuador 3
GR - Grecia 3
LT - Lituania 3
ZA - Sudafrica 3
BE - Belgio 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
ES - Italia 2
ET - Etiopia 2
IL - Israele 2
IR - Iran 2
KG - Kirghizistan 2
MA - Marocco 2
MO - Macao, regione amministrativa speciale della Cina 2
PT - Portogallo 2
PY - Paraguay 2
RS - Serbia 2
UA - Ucraina 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CR - Costa Rica 1
EE - Estonia 1
GE - Georgia 1
IQ - Iraq 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MY - Malesia 1
RO - Romania 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.207
Città #
Moscow 714
Singapore 166
Hong Kong 157
Dublin 124
Santa Clara 99
Chandler 81
Hefei 70
Seoul 70
The Dalles 62
New York 41
Naples 38
Ashburn 36
Bengaluru 30
Beijing 25
Dallas 25
Ho Chi Minh City 24
Munich 17
São Paulo 13
Los Angeles 12
Cambridge 11
Princeton 11
Roxbury 11
Caserta 10
Falkenstein 10
Salerno 8
Hanoi 7
Liveri 7
Atlanta 6
Bremen 6
Stockholm 6
Chennai 5
Florence 5
Lahore 5
Milan 5
Baku 4
Belo Horizonte 4
Brasília 4
Brooklyn 4
Da Nang 4
Damietta 4
Denver 4
Des Moines 4
Helsinki 4
Istanbul 4
Mexico City 4
Paris 4
Vienna 4
Amsterdam 3
Andover 3
Bexley 3
Boydton 3
Can Tho 3
Chengdu 3
Dhaka 3
Guarulhos 3
Guayaquil 3
Houston 3
Lappeenranta 3
Manaus 3
Mumbai 3
Norwalk 3
Nuremberg 3
Rio de Janeiro 3
Seattle 3
Shenzhen 3
Terzigno 3
Toronto 3
Warsaw 3
Zurich 3
Addis Ababa 2
Andria 2
Asunción 2
Athens 2
Avellino 2
Banda Aceh 2
Bari 2
Belgrade 2
Bishkek 2
Biên Hòa 2
Boardman 2
Bogotá 2
Boston 2
Brno 2
Brussels 2
Buenos Aires 2
Cagliari 2
Camden 2
Campinas 2
Ecatepec 2
Frankfurt am Main 2
Guastalla 2
Ha Long 2
Honolulu 2
Hải Dương 2
Itabira 2
Jacksonville 2
Johannesburg 2
La Paz 2
Lima 2
Lisbon 2
Totale 2.097
Nome #
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 160
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 154
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 140
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 135
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 132
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 132
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 129
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 128
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 126
Cardiovascular benefits from gliflozins: Effects on endothelial function 123
HCC and molecular targeting therapies: Back to the future 121
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 117
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 116
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 112
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 107
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 107
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 104
Pathophysiology, Functional Assessment and Prognostic Implications of Nutritional Disorders in Systemic Amyloidosis 102
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 102
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 102
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 102
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 102
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 101
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions 100
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 100
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 100
Editorial - Direct-acting antivirals therapy in HCV patients with HCC: lights and shadow 99
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 97
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 95
null 93
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 92
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 91
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 81
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 76
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 76
Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice 71
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 64
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 62
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 61
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 59
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 58
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 41
Totale 4.270
Categoria #
all - tutte 14.252
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.252


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 1 0 1 0 0 2 10
2021/202294 1 0 0 17 20 6 4 2 3 2 11 28
2022/2023292 17 15 8 17 35 16 4 22 133 8 5 12
2023/2024234 31 11 6 18 47 36 4 9 5 15 22 30
2024/2025712 6 13 3 11 103 76 102 68 133 65 59 73
2025/20262.924 193 234 199 118 318 1.862 0 0 0 0 0 0
Totale 4.270